相关实验视频
Updated: May 30, 2025

05:38
Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
Published on: May 16, 2025
24
药物诱导的亚急性皮肤性狼与纤维化脂质降低剂相关的红斑性狼
Firas A Al-Qarqaz1, Maha M Marji2
1Department of Dermatology, Faculty of Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan; faalqarqaz@yahoo.com.
Skinmed
|January 28, 2025
概括
一名53岁的妇女在开始服用纤维化药物后出现了严重的皮肤皮疹,可能是光皮炎. 尽管进行了局部治疗,但喷发恶化,突出显示了药物诱导的潜在光敏感性.
科学领域:
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 一名53岁的女性患有糖尿病,高脂血症和维生素D缺乏症,出现了面部和身体的发疹.
- 她已经服用甲型胺,萨克萨格利普丁,阿托瓦斯塔丁,维生素B12,维生素D,兰索普拉和阿司匹林4年了.
研究的目的:
- 在一个患有多种并发病症的患者中调查一种可能与纤维酸相关的光皮炎病例.
主要方法:
- 临床病例介绍详细介绍患者病史,检查结果和治疗过程.
- 根据症状和暴露在阳光下,考虑对光皮炎的诊断.
主要成果:
- 患者在治疗超脂血症时服用芬芳纤维化剂后,在阳光照射和阳光覆盖的部位出现了红血状,状的喷发.
- 局部治疗包括甲基prednisoloneaceponate,pimecrolimus和防晒剂提供了最小的缓解,与恶化的皮肤炎在干部和四肢.
结论:
- 纤维酸盐可能会诱发或加剧光皮炎,即使在阳光照射的区域.
- 在具有类似表现的患者中,对药物诱导的光敏感性进行进一步的研究是有必要的.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
524
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
524
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
141
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
141
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
114
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
114
Ultrasound II: Endoscopic Ultrasound and FibroScan
74
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
74
Drugs for Treatment of Constipation-Predominant IBS
131
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
131
Drugs for Treatment of Ulcerative Colitis in IBD
118
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
118

